ROMER MOSQUERA: Open Payments
NPI 1790930782 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 29 payments from 12 companies in 2025. Trend: 2023 $371 · 2024 $368 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $167 |
| Lilly USA, LLC | 4 | $110 |
| ABBVIE INC. | 4 | $92 |
| Alexion Pharmaceuticals, Inc. | 3 | $89 |
| Cranial Technologies, Inc | 3 | $52 |
| Azurity Pharmaceuticals, Inc. | 1 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Corium, LLC | 1 | $23 |
| SpringWorks Therapeutics, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $21 |
Products named: WAINUA, KISUNLA, ULTOMIRIS, QULIPTA, Doc Band, ZONISADE, ZORYVE, Azstarys.
Industry payments across FL — which companies pay providers there.
